August 2005 • www.clinicalneurologynews.com Dementias 11

elevated NTP level and 35 had a normal NTP level can help discriminate between Assay Was One Part of Diagnosis level. The 43 patients with MCI were split, probable AD and a patient with definite Urine Test from page 1 with 22 having an elevated level and 21 non-AD, a significant number of patients having a normal level. Only 4 of the 44 pa- in the possible AD and MCI categories in conjunction with, and not in lieu of, sive specialist exam using National Insti- tients with definite non-AD had an ele- had NTP levels on both sides of the cut- current standard diagnostic procedures, to tute of Neurological and Communicative vated NTP level. off. This indicates that the test may have aid the in the diagnosis of defi- Disorders and Stroke–Alzheimer’s Disease The sensitivity of the test—the propor- little value in distinguishing these two nite non-AD versus probable AD, possible and Related Disorders Association tion of patients in the “not definite non- groups from the other two groups, rais- AD or MCI [mild cognitive impairment].” (NINCDS-ADRDA) criteria for diagnosing AD” category who had an elevated NTP ing the concern over the value of the test Nymox CEO Paul Averback, M.D., em- probable AD. measurement—was 60% (94 of 156 pa- in clinical practice. phasized that the test should not be con- Patients had the urine NTP measure- tients), according to the company’s analy- Panelist Joseph Parisi, M.D., professor of sidered a stand-alone diagnostic, but, ment and, based on a comprehensive eval- sis of the results. at the Mayo Clinic, Rochester, rather, “a measurement that adds useful uation that included a neurocognitive as- The specificity of the test—the propor- Minn., raised the issue of whether NTP information” and “moves the diagnosis sessment, a Mini Mental State tion of those with definite served as a reliable biomark- along.” He said the test was particularly Examination, and structural imaging with non-AD with a normal The test may er of the disease. useful for primary care , al- CT, MRI, or other scans, were classified as NTP measurement—was have had little “Ideally, a biomarker though it is intended for use by specialists having probable AD, possible AD MCI, or 91% (40 of 44 patients). should have some kind of as well. The FDA usually follows the rec- definite non-AD. The positive predictive value relationship to disease ommendations of its advisory panels, Patients categorized as “definite non- value—the percentage of distinguishing pathogenesis, and I don’t which are not binding. A statement issued AD” were determined to have conditions patients with elevated NTP think we have data to sup- by Nymox after the panel’s vote said that that included age-related memory de- in the “not definite non- patients with port that point.” He also the company will continue to pursue ap- cline, pseudodementia due to depression, AD” category—was nearly probable AD and found the data on the test’s proval of the test kit and would work with and metabolic disorders. An elevated NTP 96% (94 of 98 patients). sensitivity and specificity the FDA to meet possible requirements was set at above 22 mcg/mL, with a nor- The negative predictive val- definite non-AD conflicting. for more data resulting from the panel’s mal level at 22 mcg/mL or less; the test ue—the percentage of sub- from those with Other concerns raised by suggestions. was performed on a first morning urine jects with normal NTP Dr. Mani and panel mem- The panel’s vote was based on the re- sample. who were in the definite possible AD or bers included the intrasub- sults of a prospective study of 200 patients Nearly 80% (156 patients) had probable non-AD category—was MCI. ject biologic variability seen presenting to one of nine cognitive/mem- AD, possible AD, or MCI and were nearly 40% (40 of 102), ac- in a small number of sub- ory disorder centers for an evaluation by lumped together in the category of “not cording to Nymox. jects who had more than one test and the experts in AD and related cognitive disor- definite non-AD” in the study. Of the 57 Brain biopsy results confirming the di- high proportion of NTP measurements in ders. The aim of the study was to show patients with probable AD, 51 had an ele- agnosis in a subject with clinically proba- the four diagnostic categories that clus- that the NTP test had a high degree of cor- vated NTP level and 6 had a normal lev- ble AD and an elevated NTP test were tered around the cutoff point. Some un- relation with the results of a comprehen- el. Of the 56 with possible AD, 21 had an available in only one patient, a 39-year-old certainty remained as to whether urine man with a family history of early-onset NTP levels could be elevated in patients AD who died 2 years after diagnosis. This with other neurodegenerative diseases. REQUIP® (ropinirole hydrochloride) Tablets terminology. These categories are used in the listing below. The frequencies presented represent the proportion of the 911 individuals exposed to REQUIP who case was one of the clinical examples cit- Neurologist Avindra Nath, M.D., Ph.D., experienced events of the type cited on at least one occasion while receiving REQUIP. All reported events that occurred at least twice (or once for serious or potentially serious events), except those already listed, trivial events, and terms too vague to be meaningful, are included without regard to determination of a causal relationship to ed by the company to illustrate the use- of Johns Hopkins University, Baltimore, a REQUIP, except that events very unlikely to be drug-related have been deleted. Events are further classified within body system categories and enumerated in order of decreasing frequency using the following definitions: frequent adverse events are defined as those occurring in at least 1/100 patients and infrequent adverse events are fulness of the test, particularly for prima- panelist, said he was not entirely con- those occurring in 1/100 to 1/1,000 patients. Blood and Lymphatic System Disorders: Infrequent: Anemia, lymphadenopathy. Cardiac Disorders: Frequent: Palpitations. Infrequent: Acute coronary syndrome, angina pectoris, angina unstable, bradycardia, cardiac failure, cardiovascular disorder, coronary artery disease, ry care physicians. vinced that the study was adequate to myocardial infarction, sick sinus syndrome, tachycardia. Congenital, Familial, and Genetic Disorders: Infrequent: Pigmented nevus. Ear and Labyrinth Disorders: Infrequent: Ear pain, middle ear effusion, tinnitus. Endocrine Disorders: Infrequent: Goiter, hypothyroidism. Eye Disorders: Infrequent: Company documents included the case justify its intended use, citing the small Blepharitis, conjunctival hemorrhage, conjunctivitis, eye irritation, eye pain, keratoconjunctivitis sicca, vision blurred, visual acuity reduced, visual disturbance. Gastrointestinal Disorders: Frequent: Abdominal pain, , gastroesophageal reflux disease, stomach discomfort, toothache. Infrequent: Abdominal of a 73-year-old woman, with a 4- to 6- sample and the lack of longitudinal data adhesions, abdominal discomfort, abdominal distension, abdominal pain lower, duodenal ulcer, dysphagia, eructation, flatulence, gastric disorder, gastric hemorrhage, gastric polyps, gastric ulcer, , gastrointestinal pain, , , hiatus , intestinal obstruction, , loose stools, month history of forgetfulness, problems on the patients. mouth ulceration, acute, peptic ulcer, rectal hemorrhage, reflux . General Disorders and Administration Site Conditions: Frequent: Asthenia, chest pain, influenza-like illness, rigors. Infrequent: Chest discomfort, feeling cold, feeling hot, hunger, lethargy, malaise, edema, pain, pyrexia. performing activities of daily living, and an A longitudinal study could answer Hepatobiliary Disorders: Infrequent: , cholelithiasis, ischemic . Immune System Disorders: Infrequent: Hypersensitivity. elevated NTP of 33 mcg/mL. She was di- some outstanding questions, such as the and Infestations: Frequent: Bronchitis, , gastroenteritis viral, lower respiratory tract , rhinitis, tooth abscess, urinary tract infection. Infrequent: , bacterial infection, bladder infection, bronchitis acute, candidiasis, cellulitis, cystitis, infectious, , ear infection, folliculitis, agnosed with probable AD and over the outcome of patients with “possible” AD, fungal infection, gastrointestinal infection, herpes simplex, infected cyst, laryngitis, localized infection, mastitis, otitis externa, otitis media, pharyngitis, pneumonia, postoperative infection, respiratory tract infection, tonsillitis, tooth infection, vaginal candidiasis, vaginal infection, vaginal mycosis, viral infection, viral upper respiratory next 2 years, declined significantly and he added. He and other panelists ob- tract infection, wound infection. Injury, Poisoning, and Procedural Complications: Infrequent: Concussion, lower limb fracture, post procedural hemorrhage, road traffic accident. Investigations: Infrequent: Blood cholesterol increased, blood iron decreased, blood pressure increased, blood urine present, hemoglobin was institutionalized, despite treatment. In served that primary care physicians would decreased, heart rate increased, protein urine present, weight decreased, weight increased. Metabolism and Nutrition Disorders: Infrequent: Anorexia, decreased appetite, diabetes mellitus non-insulin-dependent, fluid retention, gout, hypercholesterolemia. Musculoskeletal and Connective Tissue Disorders: Frequent: another case, a 72-year-old man whose likely refer any patient with memory Muscle spasms, musculoskeletal stiffness, myalgia, neck pain, osteoarthritis, tendonitis. Infrequent: Arthritis, aseptic necrosis bone, bone pain, bone spur, bursitis, groin pain, intervertebral disc degeneration, intervertebral disc protrusion, joint stiffness, joint swelling, localized osteoarthritis, monoarthritis, muscle contracture, muscle cognitive function had declined for 1-2 problems to a specialist, regardless of the tightness, muscle twitching, osteoporosis, rotator cuff syndrome, sacroiliitis, synovitis. Neoplasms Benign, Malignant, and Unspecified: Infrequent: Anaplastic thyroid cancer, angiomyolipoma, basal cell carcinoma, breast cancer, gastric cancer, gastrointestinal stromal tumor, malignant melanoma, prostate cancer, skin papilloma, years and who had diffuse atrophy, promi- NTP result. squamous cell carcinoma, uterine leiomyoma. Nervous System Disorders: Frequent: Hypoesthesia, migraine. Infrequent: Amnesia, aphasia, ataxia, balance disorder, benign intracranial hypertension, burning sensation, carpal tunnel syndrome, disturbance in attention, dizziness postural, dysgeusia, dyskinesia, head nent ventricles, and white matter lesions One of the two panelists who voted discomfort, hyperesthesia, hypersomnia, lethargy, loss of consciousness, memory impairment, migraine with aura, migraine without aura, neuralgia, sciatica, sedation, sinus headache, sleep apnea syndrome, syncope vasovagal, tension headache, transient ischemic attack, tremor. Psychiatric Disorders: Frequent: Anxiety, on MRI, but a normal neurologic exam against the motion of nonapprovable for depression, irritability, sleep disorder. Infrequent: Abnormal dreams, agitation, bruxism, confusional state, depressed mood, disorientation, early morning awakening, libido decreased, loss of libido, mood swings, nervousness, nightmare, panic attack, stress symptoms, tension. Renal and Urinary Disorders: Infrequent: Dysuria, and a normal NTP level of 19.4, was de- the test, Oscar L. Lopez, M.D., associate hematuria, hypertonic bladder, micturition disorder, nephrolithiasis, nocturia, pollakiuria, proteinuria, urinary retention. Reproductive System and Breast Disorders: Frequent: Erectile dysfunction. Infrequent: Breast cyst, dysmenorrhea, menorrhagia, pelvic peritoneal adhesions, postmenopausal hemorrhage, termined as falling in the definite non-AD professor of at the University of premenstrual syndrome, prostatitis. Respiratory, Thoracic and Mediastinal Disorders: Frequent: Asthma, pharyngolaryngeal pain. Infrequent: Dry throat, dyspnea, epistaxis, hemoptysis, hoarseness, interstitial lung disease, nasal mucosal disorder, nasal polyps, respiratory tract congestion, rhinorrhea, sinus congestion, category, and was normal over 2 years of Pittsburgh, remarked that the test proba- sneezing, wheezing, yawning. Skin and Subcutaneous Tissue Disorders: Frequent: Night sweats, rash. Infrequent: Acne, actinic keratosis, alopecia, cold sweat, follow-up. bly would be useful for primary care physi- dermatitis, dermatitis allergic, dermatitis contact, eczema, exanthem, face edema, photosensitivity reaction, pruritus, psoriasis, rash pruritic, skin lesion, urticaria. Vascular Disorders: Frequent: Hot flush, hypertension, . Infrequent: atherosclerosis, circulatory collapse, flushing, hematoma, , varicose vein. But Ranjit Mani, M.D., a neurologist cians in rural areas who have no close ac- DRUG ABUSE AND DEPENDENCE Controlled Substance Class: REQUIP is not a controlled substance. and medical reviewer in the FDA’s divi- cess to specialists, although he added that Physical and Psychological Dependence: Animal studies and human clinical trials with REQUIP did not reveal any potential for drug-seeking behavior or physical dependence. sion of neuropharmacologic drug prod- the test results would not provide much in- OVERDOSAGE In the Parkinson’s disease program, there have been patients who accidentally or intentionally took more than their prescribed dose of ropinirole. The largest overdose ucts, Rockville, Md., pointed out that formation for the specialist who can make reported in the Parkinson’s disease clinical trials was 435 mg taken over a 7-day period (62.1 mg/day). Of patients who received a dose greater than 24 mg/day, reported symptoms included adverse events commonly reported during dopaminergic (nausea, dizziness), as well as visual hallucinations, hyperhidrosis, claustrophobia, while the results demonstrated that the the diagnosis without the test. ■ chorea, palpitations, asthenia, and nightmares. Additional symptoms reported for doses of 24 mg or less or for overdoses of unknown amount included vomiting, increased coughing, fatigue, syncope, vasovagal syncope, dyskinesia, agitation, chest pain, orthostatic hypotension, somnolence, and confusional state. Overdose Management: It is anticipated that the symptoms of overdose with REQUIP will be related to its dopaminergic activity. General supportive measures are recommended. Vital signs should be maintained if necessary. Removal of any unabsorbed material (e.g., by gastric lavage), should be considered. Dosing Consideration for Parkinson’s Disease and RLS: If a significant interruption in therapy with REQUIP has occurred, retitration of therapy may be warranted. Hypertension May Impair Memory

GlaxoSmithKline Research Triangle Park, NC 27709 mpaired cerebral blood flow may con- nificantly blunted in certain areas of the © 2005, GlaxoSmithKline. All rights reserved. May 2005 BRS-RQ:L11 Itribute to the mild deficits in memory brain in hypertensive subjects, who also and other cognitive functions in people showed mild deficits in performance, com- with hypertension, compared with their pared with the normotensive subjects normotensive peers, according to J.R. Jen- (Neurology 2005;64:1358-65). nings, Ph.D., of the University of Pitts- “Our results are far from conclusive but ©2005 The GlaxoSmithKline Group of Companies All rights reserved. Printed in USA. RQP275R0 July 2005 burgh, and associates. suggest that vascular factors may play a The researchers assessed regional cere- role” in mild memory and cognitive bral blood flow using MRI and PET brain deficits seen in hypertensive people, the re- scans in 37 hypertensive and 59 nor- searchers said. Moreover, the findings motensive subjects (median age 60 years) show that common systemic diseases such who performed a battery of memory and as hypertension can have unanticipated ef- sensorimotor tasks. The blood flow re- fects on brain function, they added. sponse to performance demands was sig- —Mary Ann Moon